Celanese Corp. Q2 2008 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended June 30, 2008. Celanese Corporation is a global integrated chemical and advanced materials company. The financial statements are presented on an unaudited basis and separate discontinued operations from continuing operations.
Key Financial Metrics
| Metric | Q2 2008 | Q2 2007 | YTD 2008 | YTD 2007 |
|---|---|---|---|---|
| Net Sales ($ millions) | 1,868 | 1,556 | 3,714 | 3,111 |
| Gross Profit ($ millions) | 396 | 337 | 814 | 696 |
| Operating Profit ($ millions) | 207 | 71 | 441 | 277 |
| Net Earnings ($ millions) | 134 | (117) | 279 | 84 |
| Diluted EPS ($) | 0.80 | (0.76) | 1.67 | 0.50 |
| Cash and Equivalents ($ millions) | 983 | — | 983 | — |
| Total Debt ($ millions) | 3,623 | — | 3,623 | — |
| Operating Cash Flow ($ millions) | — | — | 346 | 79 |
Note: Q2 2007 and YTD 2007 balance sheet data not provided in this excerpt; Cash Flow data is YTD only.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 20% in Q2 and 19% YTD compared to 2007. Growth was driven by higher prices (11% impact) and favorable foreign currency impacts (6-7% impact), partially offset by volume declines in some segments.
- Profitability: Operating profit surged 191% in Q2 and 59% YTD. This improvement is largely due to higher gross profit and a significant reduction in "Other (charges) gains, net" compared to 2007.
- One-Time Items: The 2007 period included a $256 million refinancing expense and $74 million in deferred compensation charges related to an "Exit Event," which were absent in 2008, significantly boosting comparative earnings.
- Discontinued Operations: Q2 2008 included a $107 million legal settlement charge related to polyester staple antitrust litigation, resulting in a $69 million loss from discontinued operations for the quarter.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects capital expenditures to be approximately $300 million for the full year 2008.
- Expansion: The company is expanding its integrated chemical complex in Nanjing, China, with new facilities for acetic acid, VAM, and UHMW-PE coming online or ramping up.
- Liquidity: The company maintains $650 million in available borrowing capacity under its revolving credit facility and $98 million under its credit-linked facility. Cash and cash equivalents increased to $983 million.
- Risks:
- Regulatory: Potential restrictions on Vinyl Acetate Monomer (VAM) in Canada and the EU (REACH) could impact demand.
- Legal: Ongoing exposure to sorbates antitrust actions (reserve of $184 million) and plumbing product liability claims (reserve of $65 million).
- Market: Volatility in raw material prices (methanol, ethylene) and energy costs.
Investor Verification Checklist
- Discontinued Operations Impact: Verify the long-term implications of the $107 million polyester staple settlement and the status of the sorbates antitrust reserve ($184 million).
- Margin Sustainability: Assess whether the 20% revenue growth and margin expansion can be sustained given rising raw material and energy costs.
- Cash Flow Quality: Review the $346 million operating cash flow YTD, noting the $59 million VAT receipt from Fraport (Ticona relocation) which is a non-recurring inflow.
- Debt Covenants: Confirm continued compliance with debt covenants, particularly given the $3.6 billion total debt load.
- China Expansion: Monitor the operational ramp-up and cost performance of the Nanjing, China complex.